Madison Square Garden Entertainment Corp. Q4 FY2026 earnings call

• Overall Full Year Performance

  • Fiscal 2026 delivered outstanding results with double-digit revenue and adjusted operating income growth across all key business areas.
  • The company repurchased $25 million of Class A common stock during fiscal 2026, with $205 million in total repurchases completed since the 2023 spinoff, advancing core capital allocation priorities.

• Venue Operations and Event Growth

  • Full fiscal 2026 hosted 6.4 million guests across nearly 960 live events. Q4 2026 more than doubled Garden concert volume year-over-year during the NBA playoff window, with most concerts selling out.
  • The proposed Infosys Theater transfer as part of the Penn Station Redevelopment Project was announced, with the arena to remain fully operational during construction if the transaction is finalized. Negotiations of definitive agreements are ongoing.

• Christmas Spectacular Production

  • Fiscal 2026 Christmas Spectacular set a 25-year attendance record of 1.2 million tickets sold across 215 paid performances, generating a record $195 million in revenue.
  • The 2026 holiday season will have 230 performances (a new annual high) and add a new rocket scene and immersive technology to innovate the 93rd season.

• MSG Sports Shared Revenue

  • The Knicks' 2025-26 season and championship run drove robust year-over-year per-game growth in all shared revenue streams, including F&B, merchandise, and suites. Momentum is expected to carry into fiscal 2027.
  • Fiscal 2027 arena license fee cash component is set at $47 million, with 3% annual growth through 2055.

• Marketing Partnerships and Premium Hospitality

  • Fiscal 2026 added new multi-year partners including Calshi, and renewed multi-year contracts with Lexus, Anheuser-Busch, and Infosys.
  • Strong new sales and renewal activity for renovated Garden suites continued in fiscal 2026, with additional suite renovations planned for fiscal 2027 to drive incremental revenue.

Segment-level performance details were not explicitly broken out by individual product segment in the call. Consolidated results for fiscal 2026 Q4 and full year are as follows:

• Q4 2026: Revenues of $196.3 million, up 27% year-over-year. Adjusted operating income was $18.6 million, a $19.9 million improvement from a $1.3 million adjusted operating loss in the prior year quarter. Revenue growth was driven by higher entertainment offering revenue, increased food, beverage, and merchandise (F&B&M) revenue, and growing venue sponsorship, signage, and suite license revenue, partially offset by fewer concerts at company theaters. A $7.4 million Q4 revenue increase was attributed to shared revenue streams with MSG Sports from the Knicks' 2026 NBA championship run.
• Full fiscal 2026: Total consolidated revenues exceeded $1 billion, up 13% year-over-year. Adjusted operating income was $262 million, up 18% year-over-year.

• Management expects solid year-over-year growth in both revenues and adjusted operating income for fiscal 2027, building on fiscal 2026 operating momentum.
• The company expects to grow the total number of events across its venue portfolio year-over-year, with growth driven primarily by concerts, and secondarily by special events and marquee sports. High-profile upcoming events include the 30-date Harry Styles residency at the Garden (August-October 2026) and the return of the NCAA Men's Basketball East Regionals to the Garden in March 2027.
• Booking pacing as of the call: the Garden is 90% to its 2027 full-year booking goal, while theaters are 60% to goal. Fiscal 2027 Q1 is on track to set a new record for Garden concerts in a single quarter, and the Garden is pacing ahead of last year for Q4 2027 concerts, while theaters are currently pacing behind prior year levels, which is consistent with the typical 3-6 month theater booking window.
• The company expects to generate significant underlying free cash flow in fiscal 2027, driven by growing adjusted operating income, partially offset by net interest payments, full cash tax payments, incremental capital expenditures for company-wide technology investments and Garden suite renovations, and working capital timing changes.
• For the 2026 Christmas Spectacular, management expects ticketing revenue growth from both a mid-single-digit increase in the number of performances and higher average ticket yields, supported by product innovations.

• The proposed Infosys Theater transfer remains subject to negotiation of definitive agreements, and no final terms or closing have been confirmed.
• Fiscal 2027 family show bookings face a difficult year-over-year comparison due to the absence of 2026's Cirque du Soleil holiday runs at the Infosys Theater and Chicago Theater, though management expects this impact to be largely offset by other attractions.
• Residency transitions can create near-term booking volatility, as seen after the conclusion of the Billy Joel residency at the Garden, which requires active ongoing outreach to secure replacement long-term residency bookings.

Q: What is the current status of the Infosys Theater transfer, and how much of the venue's event volume and sponsorship economics can be recaptured across the company's other assets? / A: Management is currently negotiating definitive agreements with the selected Penn Station master developer, and will update investors as progress is made. A significant majority of the company's total economics come from Madison Square Garden and the Christmas Spectacular, so the theater contributes a smaller share of overall revenue. Management is evaluating shifting events to other New York-based theaters, and existing sponsorship agreements generally provide flexibility to move branding across the company's venue portfolio to preserve partner value. (347 characters)

Q: What is your 2026 Christmas Spectacular sales pacing, pricing strategy, and ability to add more performances beyond the planned 230 shows if demand is strong? / A: While the sales cycle is still early, management expects ticketing revenue growth this year from both more performances and higher average ticket yields. The Christmas Spectacular is still priced below comparable premium New York entertainment options, so the company will continue to thoughtfully price and market inventory to maximize total revenue. New content and immersive technology are expected to drive increased consumer interest for the 2026 holiday season. (371 characters)

Q: After the transition from the Billy Joel residency, what operational changes have you made to reduce future volatility from residency changes, and how is the pipeline looking? / A: Residencies remain a core strategic priority for the bookings team, as they create recurring revenue and improve forward calendar visibility. Every residency has a unique structure: Billy Joel had one monthly show, while the new Harry Styles residency has 30 shows over 10 weeks. Multiple other active and extended residencies are already booked across the company's venues for the first half of fiscal 2027, and management is in ongoing discussions with additional artists for future residencies across all venues. (412 characters)

Q: What revenue streams benefited from the Knicks' championship run, and how large was the overall boost? / A: The company shares profits with MSG Sports for in-arena F&B (50% of net profits to MSGE), retains 30% of net merchandise revenue, and earns commissions on single-night suite rentals for Knicks and Rangers games. Nine Knicks playoff games were hosted in Q4 2026, leading to a total $7.4 million year-over-year increase in Q4 revenue from these shared streams, driven by elevated fan demand for merchandise and F&B. Strong team performance is also expected to boost in-arena attendance and shared revenue in fiscal 2027. (398 characters)